The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
Crossref DOI link: https://doi.org/10.1186/s12879-017-2316-x
Published Online: 2017-03-24
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brekke, Kristin
Sommerfelt, Maja
Ökvist, Mats
Dyrhol-Riise, Anne Margarita
Kvale, Dag